Our passion for science and innovation has led us to sign a collaboration agreement with the Catholic University of Valencia (UCV). This agreement marks an important milestone in our commitment to develop supplements backed by the best scientific evidence available. We are close to starting a clinical trial aimed at exploring the benefits of our SatiSens supplement, reinforcing our vision of a future where science and well-being are integrated to improve people's quality of life.
At IVB, we work to ensure that our products are supported by meta-analyses and clinical trials, guaranteeing their efficacy and safety. Recently, the prestigious journal Nutrition Reviews has published a meta-analysis on PEA led by our Medical-Scientific Director, Dr. Isabel Viñas Bas, in collaboration with Miguel López-Moreno from the Francisco de Vitoria University. This study showed that palmitoylethanolamide (PEA) significantly reduces pain in 4 to 8 weeks, improving the quality of life of patients. We are proud to connect this knowledge with the development of our ZeroDol, a supplement with a high concentration of PEA, designed to treat different types of pain (nociceptive, neuropathic and nociplastic).
Our commitment goes beyond the formulation of innovative, safe and science-backed supplements. We also want to accompany and advise you to make informed decisions that generate a positive impact on your health. The experience and dedication of our team allow us to offer you effective solutions to improve your well-being and quality of life.
The IVB supplements you need
Your cart is currently empty.
Start Shopping
